Moreover, FOXM1 expression exhibited an increasing trend across clinical stages I to III and was overexpressed in all stages examined ( Fig.
← all excerpts
Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma.
1
—
—